Growing evidence suggests that the endocannabinoid system is involved in the pathogenesis of Alzheimer's disease (AD) and atherosclerosis.
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline / Altamura, C., Ventriglia, M., Martini, M.G., Montesano, D., Errante, Y., Piscitelli, F., Scrascia, F., Quattrocchi, C., Palazzo, P., Seccia, S., Vernieri, F., Di Marzo, V.. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1875-8908. - 46:2(2015), pp. 497-506. [10.3233/JAD-142349]
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline
MONTESANO, DOMENICO;SECCIA, SERENELLA;
2015
Abstract
Growing evidence suggests that the endocannabinoid system is involved in the pathogenesis of Alzheimer's disease (AD) and atherosclerosis.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
seccia et al. 2015.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
4.44 MB
Formato
Adobe PDF
|
4.44 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
